← SynDRA
CHRYSOPHANOL
SynDRA canonical compound SYN0002134 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | MTOR |
|---|
| Mechanism of action | EGFR inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- AKR1A1
- NR3C1
- USP2
- USP1
- UGT1A9
- UGT1A6
- UGT1A1
- TTR
- TSHR
- TDP1
- SLCO1B3
- SLCO1B1
- RORC
- RECQL
- POLK
- P2RY12
- NFE2L2
- AKR1B1
- MGAM
- MAPT
- MAPK1
- KDM4E
- HDAC6
- EPHX2
- ELANE
- EHMT2
- CYP3A4
- CTSG
- BRCA1
- APEX1
- ALDH1A1
- AKR1B10
- VDR
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- AHR
- ANDR
- CP1A2
- ESRRA
- GPX1
- HDAC9
- NF2L2
- PRGR
Drug classes
Cross-references
Synonyms
- chrysophanic-acid
- CHRYSOPHANIC ACID
- 1,8-dihydroxy-3-methylanthracene-9,10-dione
- 3-Methylchrysazin
- 1,8-Dihydroxy-3-methylanthraquinone
- 1,8-Dihydroxy-3-methyl-9,10-anthracenedione
- C.I. Natural Yellow 23
- 4,5-Dihydroxy-2-methylanthraquinone
- 3-Methyl-1,8-dihydroxyanthraquinone
- 2-Methyl-4,5-dihydroxyanthraquinone
- C.I. 75400
- 1,8-dihydroxy-3-methyl-9,10-anthraquinone
- N1ST8V8RR2
- NSC 37132
- NSC 646567
- CHEBI:3687
- Anthraquinone, 1,8-dihydroxy-3-methyl-
- DTXCID704832
- RefChem:32517
- Turkey rhubarb
- Crysophanol
- Crysophanic acid
- 1,8-Dihydroxy-3-Methyl-Anthraquinone
- Rumicin
- MFCD00001208
- Chrysophanol (Standard)
- Chrysophanic acid (Chrysophanol)
- 1,8-dihydroxy-3-methyl-anthracene-9,10-dione
- 9,10-Anthracenedione, 1,8-dihydroxy-3-methyl-
- NSC646567
- Chrysophanic acid (1,8-dihydroxy-3-methylanthraquinone)
- 1,8-Dihydroxy-3-methylanthra-9,10-quinone
- CCRIS 3525
- EINECS 207-572-2
- UNII-N1ST8V8RR2
- chirysophanol
- Archinin
- Chrysophansaeure
Look up CHRYSOPHANOL in the interactive SynDRA portal →